Alexion Pharmaceuticals (ALXN)

Add to Watchlists
Create an Alert
122.96 +0.95  +0.78% NASDAQ Dec 2, 20:00 Delayed 2m USD

Alexion Pharmaceuticals Revenue (TTM):

2.954B for Sept. 30, 2016
View 4,000+ financial data types
Browse...
View Full Chart

Alexion Pharmaceuticals Revenue (TTM) Chart

Export Data
Save Image
Print Image

Alexion Pharmaceuticals Historical Revenue (TTM) Data

View and export this data going back to 1995. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2016 2.954B
June 30, 2016 2.822B
March 31, 2016 2.705B
Dec. 31, 2015 2.604B
Sept. 30, 2015 2.503B
June 30, 2015 2.391B
March 31, 2015 2.267B
Dec. 31, 2014 2.234B
Sept. 30, 2014 2.076B
June 30, 2014 1.921B
March 31, 2014 1.779B
Dec. 31, 2013 1.551B
Sept. 30, 2013 1.430B
June 30, 2013 1.324B
March 31, 2013 1.228B
Dec. 31, 2012 1.134B
Sept. 30, 2012 1.041B
June 30, 2012 951.06M
March 31, 2012 862.04M
Dec. 31, 2011 783.43M
Sept. 30, 2011 711.85M
June 30, 2011 649.37M
March 31, 2011 589.50M
Dec. 31, 2010 540.96M
Sept. 30, 2010 495.63M
   
June 30, 2010 456.69M
March 31, 2010 423.11M
Dec. 31, 2009 386.80M
Sept. 30, 2009 353.55M
June 30, 2009 327.42M
March 31, 2009 294.72M
Dec. 31, 2008 259.10M
Sept. 30, 2008 215.56M
June 30, 2008 161.17M
March 31, 2008 111.36M
Dec. 31, 2007 72.04M
Sept. 30, 2007 38.37M
June 30, 2007 16.52M
March 31, 2007 7.107M
Dec. 31, 2006 1.558M
Sept. 30, 2006 1.935M
June 30, 2006 1.62M
March 31, 2006 1.665M
Oct. 31, 2005 1.46M
July 31, 2005 1.042M
April 30, 2005 5.241M
Jan. 31, 2005 5.025M
Oct. 31, 2004 4.609M
July 31, 2004 4.609M
April 30, 2004 0.629M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Revenues

Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity. Increasing revenues over time are generally a good sign of company's growth.

While a bit obvious, if a lemonade company has sold 30 million in revenue and has 10 million in costs of goods sold, the company's revenue is still 30 million. (Expenses are not accounted in Revenue).
Learn More

Advertisement

ALXN Revenue (TTM) Benchmarks

Companies
Incyte 1.023B
Biomarin Pharmaceutical 1.045B
Vertex Pharmaceuticals 1.661B

ALXN Revenue (TTM) Range, Past 5 Years

Minimum 783.43M Dec 2011
Maximum 2.954B Sep 2016
Average 1.828B

ALXN Revenue (TTM) Excel Add-In Codes

  • Metric Code: revenues_ttm
  • Latest data point: =YCP("ALXN", "revenues_ttm")
  • Last 5 data points: =YCS("ALXN", "revenues_ttm", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

ALXN News

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.